Abstract
Küçük Hücreli Akciğer Kanseri sigara kullanımında azalmaya rağmen halen sıklıkla görülen kanserlerden birisidir. Modern tıptaki tüm gelişmelere rağmen halen hastaların birçoğu ileri evrelerde yakalanmakta ve küratif tedavi seçenekleri uygulanamamaktadır. Dolayısıyla da bu durum hastaların sağ kalımlarına yansımakta ve halen yüz güldürücü sonuçlar elde edilememektedir. Biz bu olgu sunumunda tanı anında yaygın evre gibi prezente olan ancak yapılan tetkikler sonucu her ikisininde sınırlı evre iki ayrı küçük hücreli akciğer kanseri odağı olduğunu saptadığımız bir olguyu sunduk.
References
- Ellis PM, Shepherd FA, Laurie SA, Goss GD, Olivo M, Powers J, Seymour L, Bradbury PA.
- NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and
- Etoposide in Extensive-Stage Small-Cell Lung Cancer. J Thorac Oncol. 2014 Mar;9(3):410-3.
- Ocak S, Friedman DB, Chen H, Ausborn JA, Hassanein M, Detry B, Weynand B, Aboubakar
- F, Pilette C, Sibille Y, Massion PP. Discovery of new membrane-associated proteins overexpressed in
- small-cell lung cancer. J Thorac Oncol. 2014 Mar;9(3):324-36.
- Asai N, Ohkuni Y, Kaneko N, Yamaguchi E, Kubo A. Relapsed small cell lung cancer:
- treatment options and latest developments. Ther Adv Med Oncol. 2014 Mar;6(2):69-82.
- Foresta M1, Izzotti A1, La Maestra S2, Micale R2, Poggi A3, Vecchio D4, Frosina G4.
- Accelerated Repair and Reduced Mutagenicity of DNA Damage Induced by Cigarette Smoke in
- Human BronchialCells Transfected with E.coli Formamidopyrimidine DNA Glycosylase. PLoS
- One. 2014 Jan 31;9(1):e87984.
Abstract
Despite the decline in the usage of cigarette, Small Cell Lung Cancer is one of the still often seen malignancy . Despite all the advances in modern medicine still caught in the majority of patients with advanced stage and curative treatment options are not applicable. Therefore, this situation is reflected in patient survival and still not be achieved promising results. In this case report we reported a case presenting as extensive disease at diagnosis, but the results of the examinations carried out two seperate small cell lung cancer and both of them are in the limited stage disease
References
- Ellis PM, Shepherd FA, Laurie SA, Goss GD, Olivo M, Powers J, Seymour L, Bradbury PA.
- NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and
- Etoposide in Extensive-Stage Small-Cell Lung Cancer. J Thorac Oncol. 2014 Mar;9(3):410-3.
- Ocak S, Friedman DB, Chen H, Ausborn JA, Hassanein M, Detry B, Weynand B, Aboubakar
- F, Pilette C, Sibille Y, Massion PP. Discovery of new membrane-associated proteins overexpressed in
- small-cell lung cancer. J Thorac Oncol. 2014 Mar;9(3):324-36.
- Asai N, Ohkuni Y, Kaneko N, Yamaguchi E, Kubo A. Relapsed small cell lung cancer:
- treatment options and latest developments. Ther Adv Med Oncol. 2014 Mar;6(2):69-82.
- Foresta M1, Izzotti A1, La Maestra S2, Micale R2, Poggi A3, Vecchio D4, Frosina G4.
- Accelerated Repair and Reduced Mutagenicity of DNA Damage Induced by Cigarette Smoke in
- Human BronchialCells Transfected with E.coli Formamidopyrimidine DNA Glycosylase. PLoS
- One. 2014 Jan 31;9(1):e87984.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Case Report |
| Authors | |
| Publication Date | March 3, 2015 |
| Submission Date | March 1, 2015 |
| Published in Issue | Year 2014 Volume: 5 Issue: 17 |
